Robert Baffi is VP at BIOMARIN PHARMACEUTICAL INC (BMRN). They have made 13 open-market trades across 1 company since 2006, most recently 2020-03-20.
CIK 0001274826
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
2 open-market purchases totalling $45K since 2006, against 11 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| BMRN | 117,138 | $6.4M |
Shares reported on the most recent Form 4, priced at the 2020-03-24 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| BMRN | SELL | 2018-08-07 | 2018-08-09 | $105.00 | $543K | -1.6% | -3.8% | -2.2% |
| BMRN | SELL | 2018-06-22 | 2018-06-26 | $99.00 | $688K | +6.4% | +9.4% | +4.4% |
| BMRN | SELL | 2017-09-28 | 2017-10-02 | $92.38 | $2.0M | +1.3% | -13.8% | -3.1% |
| BMRN | SELL | 2016-05-18 | 2016-05-19 | $87.05 | $435K | +2.9% | -1.0% | +9.8% |
| BMRN | SELL | 2015-03-05 | 2015-03-05 | $116.37 | $1.6M | -18.2% | +2.1% | +2.1% |
| BMRN | SELL | 2014-10-29 | 2014-10-31 | $81.34 | $6.1M | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2013-09-09 | 2013-09-11 | $73.00 | $1.5M | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2013-05-14 | 2013-05-15 | $70.00 | $1.4M | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2013-05-03 | 2013-05-07 | $67.00 | $1.3M | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2013-04-10 | 2013-04-12 | $64.00 | $1.3M | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2013-03-18 | 2013-03-20 | $61.02 | $1.2M | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2013-01-22 | 2013-01-23 | $55.00 | $1.1M | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2013-01-03 | 2013-01-07 | $53.00 | $1.1M | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2012-11-15 | 2012-11-19 | $51.00 | $1.0M | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2012-11-05 | 2012-11-07 | $47.33 | $2.8M | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2012-10-16 | 2012-10-18 | $43.00 | $860K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL | 2012-02-24 | 2012-02-28 | $34.84 | $3.2M | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · Routine | 2011-08-02 | 2011-08-04 | $30.55 | $571K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL | 2010-11-03 | 2010-11-05 | $25.24 | $50K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL | 2010-03-10 | 2013-03-20 | $22.52 | $3.7M | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2008-09-02 | 2008-09-04 | $31.31 | $361K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2008-07-30 | 2008-08-01 | $31.98 | $329K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2008-07-30 | 2008-07-31 | $31.69 | $292K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2008-06-30 | 2008-07-02 | $30.01 | $106K | -18.2% | +2.1% | +2.1% |
| BMRN | SELL · 10b5-1 | 2008-05-30 | 2008-06-03 | $38.71 | $43K | -18.2% | +2.1% | +2.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.